Below is the published article detailing the results of the three-arm phase II study
of everolimus and estrogen deprivation therapy (EDT) in advanced FLC. These results were published in May 2020.
We’re testing a new AI assistant to help patients, caregivers, and researchers find information faster. Click the FCF Assistant button in the lower right corner to try it.